MARKET

HLTH

HLTH

CUE HEALTH INC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.56
-0.11
-1.43%
After Hours: 7.80 +0.24 +3.17% 19:01 01/27 EST
OPEN
7.79
PREV CLOSE
7.67
HIGH
7.99
LOW
7.39
VOLUME
923.76K
TURNOVER
--
52 WEEK HIGH
22.55
52 WEEK LOW
7.39
MARKET CAP
1.11B
P/E (TTM)
33.64
1D
5D
1M
3M
1Y
5Y
Cramer Gives His Opinion On ADT, Occidental Petroleum And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said EQRx, Inc. (NASDAQ: EQRX) needs to be bought. "It shouldn't be independent," he added.
Benzinga · 2d ago
USPS begins shipping free at-home COVID-19 rapid tests
The United States Postal Service yesterday began shipping out free rapid COVID-19 tests to homes across the country. At a briefing today, White House COVID-19 Response Coordinator Jeffrey Zients said
Seekingalpha · 6d ago
Google’s Staff Get Pricey Fast Covid Tests While Contractors Wait
(Bloomberg) -- Google offers its full-time employees working from home a supply of high-end instant Covid-19 tests. Meanwhile, the contract workers still coming into offices have to wait longer for results.Most Read from BloombergCypriot Scientist Says Del...
Bloomberg · 01/11 21:20
Cue Health gains 4% after reporting preliminary Q4 and FY 2021 revenue above consensus
Cue Health (NASDAQ:HLTH) perks up 4% premarket after announcing preliminary Q4 and FY 2021 revenue. Q4 2021 revenue of $188M to $193M (consensus $164.01M), compared with $13M in fourth quarter 2020. The revenue reflects
Seekingalpha · 01/11 14:15
Private health insurers must cover up to 8 at-home COVID tests per month per person
Beginning Jan. 15, private health insurers must cover the cost of up to eight at-home COVID-19 tests for each covered member, according to a new requirement from the Biden administration.
Seekingalpha · 01/10 22:57
Cue Health to develop Omicron-specific COVID-19 test in partnership with BARDA
Cue Health (NASDAQ:HLTH) announces that it will develop an Omicron-Genotyping COVID-19 test to be used in professional point-of-care settings as part of the company's ongoing work with the U.S. Department
Seekingalpha · 01/06 14:29
BRIEF-Cue Health To Develop Omicron-Genotyping Covid-19 Test In Partnership With The U.S. Department Of Health And Human Services' Biomedical Advanced Research And Development Authority (Barda)
reuters.com · 01/06 14:18
Cue Health to Develop Omicron-Genotyping COVID-19 Test in Partnership with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA)
Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it will develop an Omicron-Genotyping COVID-19 test to be used in professional point-of-care settings as part of the company's ongoing work with the U.S. Department of Heal...
PR Newswire · 01/06 14:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HLTH. Analyze the recent business situations of CUE HEALTH INC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

25.00%Strong Buy
50.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average HLTH stock price target is 15.50 with a high estimate of 18.00 and a low estimate of 12.00.
High18.00
Average15.50
Low12.00
Current 7.56
EPS
Actual
Estimate
0.260.661.051.45
Q3 2020
Q4 2020
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 54
Institutional Holdings: 36.41M
% Owned: 24.88%
Shares Outstanding: 146.36M
TypeInstitutionsShares
Increased
0
0
New
54
36.41M
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Software
-1.17%
Software & IT Services
-0.70%
Key Executives
Director Nominee
Joanne Bradford
Chief Strategy Officer and Director
Chris Achar
President, Chief Executive Officer, Director, Chairman of the Board and Co-Founder
Ayub Khattak
Chief Financial Officer
John Gallagher
Director Nominee
Carole Faig
Director Nominee
Maria Martinez
General Counsel
Erica Palsis
Director
Xiangmin “Min” Cui
Director
Scott Stanford
Chief Product Officer and Co-Founder
Clint Sever
No Data
About HLTH
Cue Health Inc. is a health technology company. The Company has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.

Webull offers kinds of Cue Health Inc stock information, including NASDAQ:HLTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HLTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HLTH stock methods without spending real money on the virtual paper trading platform.